top of page

Review: Rethinking Medications is "An Important Book of Our Time"

  • May 28, 2025
  • 1 min read

This is an important book for our time ... Highly recommended!

Dr. Avorn is uniquely qualified to write this book. He writes with the authority of seasoned scholar and the clarity of a skilled communicator. High profile examples are documented to illustrate his insights. The content is extraordinarily up to date. There are discussions of implications the 2024 election, in general, and the appointment of Robert F. Kennedy Jr. as Secretary of Health and Human Services, in particular. 


“Big Pharma” is a popular target for invective these days. Avorn has plenty to criticize about the industry, but this book is not a “gotcha” attack on an unpopular target. It is a thoughtful dissection of a complex system; with careful consideration of each of the component parts: drug companies, law makers, regulators, insurance companies, and physicians. He calls members of those institutions by name. Members of his own Harvard family are not spared.


This is an important book for our time. Dr. Avorn builds his case skillfully and litigates his recommendations for reform persuasively. It is appropriate reading for medical professionals, policy makers, pharmaceutical professionals, and healthcare consumers. Highly recommended!



Recent Posts

See All
Review: Rethinking Medications

From Kirkus Reviews A masterful assessment of a highly flawed health care system. Unsettling news about prescription drugs. Avorn, professor of medicine at Harvard Medical School, reminds readers that

 
 
Review: Rethinking Medications

From Publishers Weekly A damning survey of the drug development system’s many failures, this enlightens even as it infuriates. In this troubling report, Avorn (Powerful Medicines), a professor of medi

 
 
Review: Powerful Medicines

From Kirkus Reviews Marked by solid scholarship, measured criticism, and pithy comments: an informative and highly readable study Cogent analysis of how pharmaceutical drugs are approved, promoted, an

 
 
bottom of page